New drug combo targets tough tumors in early trial
NCT ID NCT06640413
First seen Jan 15, 2026 · Last updated May 22, 2026 · Updated 24 times
Summary
This early-phase study tests a new drug, [177Lu]Lu-OncoFAP-23, alone or with another drug (L19-IL2), in people with advanced solid tumors that have a protein called FAP. The main goal is to check safety and find the best dose. About 56 adults whose cancer has worsened after standard treatments will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FAP are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
ASST Papa Giovanni XXIII Piazza OMS
RECRUITINGBergamo, Bergamo, 24127, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Fondazione IRCCS Istituto Nazionale dei Tumori
RECRUITINGMilan, Milano, 20133, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Istituto Europeo di Oncologia
NOT_YET_RECRUITINGMilan, Milano, 20141, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale" Via Mariano Semmola
NOT_YET_RECRUITINGNaples, Napoli, 80131, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.